A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors
Clinical trial NCT01832506 · COMPLETED
Trial details
- NCT number
- NCT01832506
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-30
- Primary completion
- 2014-03-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.